UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 7 | July 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 10
October-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2410459


Registration ID:
549582

Page Number

e543-e553

Share This Article


Jetir RMS

Title

Early Detection of Alzheimer's Disease Using Blood Plasma Biomarkers with Deep Learning Techniques

Abstract

The successful development of amyloid-based biomarkers and diagnostic tests for Alzheimer's disease (AD) marks a significant achievement in advancing AD diagnosis. However, two key challenges persist. First, amyloid-based biomarkers provide limited insight into the overall disease process, and second, they are ineffective in identifying individuals with AD before significant amyloid-beta accumulation in the brain occurs. This study aims to address these limitations by developing a method for identifying potential blood-based non-amyloid biomarkers for the early detection of AD. Blood is an attractive medium due to its accessibility and relatively low cost. Our approach utilizes machine learning (ML) techniques, specifically support vector machines, which are adept at building multi-variable models by identifying patterns within complex datasets. Through novel feature selection and evaluation methods, we identified five novel panels of non-amyloid proteins that show promise as early AD biomarkers. Notably, the combination of A2M, ApoE, BNP, Eot3, RAGE, and SGOT emerged as a potential key biomarker profile for early-stage AD. Detection models built using these panels achieved a sensitivity (SN) of over 99.27%, specificity (SP) exceeding 99.24%, and an area under the receiver operating curve (AUC) of at least 98.87% during the prodromal stage of the disease, with even higher performance at later stages. Comparatively, existing ML models demonstrated poor performance at this early stage, suggesting that the previously used protein panels may not be suitable for detecting AD in its early phase. Our findings underscore the feasibility of early Alzheimer's detection using non-amyloid-based biomarkers, offering a promising alternative to traditional amyloid-based diagnostics.

Key Words

Alzheimer’s Disease, Blood Plasma Biomarkers, Bi-Directional Attention Mechanism, Deep Learning

Cite This Article

"Early Detection of Alzheimer's Disease Using Blood Plasma Biomarkers with Deep Learning Techniques", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 10, page no.e543-e553, October-2024, Available :http://www.jetir.org/papers/JETIR2410459.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Early Detection of Alzheimer's Disease Using Blood Plasma Biomarkers with Deep Learning Techniques", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 10, page no. ppe543-e553, October-2024, Available at : http://www.jetir.org/papers/JETIR2410459.pdf

Publication Details

Published Paper ID: JETIR2410459
Registration ID: 549582
Published In: Volume 11 | Issue 10 | Year October-2024
DOI (Digital Object Identifier):
Page No: e543-e553
Country: Bhopal, Madhya Pradesh, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000113

Print This Page

Current Call For Paper

Jetir RMS